Performance of Subcutaneous Continuous Glucose Monitoring in Adult Critically Ill Patients Receiving Vasopressor Therapy
Diabetes Technology & Therapeutics · 2024-10 · 26 (10) · 763-772
DOI: 10.1089/dia.2024.0035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Technology & Therapeutics, online erschienen am 04.10.2024. Verfasst von Ola Friman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pharmacology, Section of Anaesthesia and Intensive Care, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Critical Illness, Blood Glucose, Vasoconstrictor Agents, Insulin. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Subcutaneous continuous glucose monitoring (CGM) may facilitate glucose control in the ICU. We aimed to assess the accuracy of CGM (Dexcom G6) against arterial blood glucose (ABG) in adult critically ill patients receiving intravenous insulin infusion and vasopressor therapy. We also aimed to assess feasibility and tolerability of CGM in this setting.
Methods
We included ICU patients receiving mechanical ventilation, insulin, and vasopressor therapy. Numerical accuracy was assessed by the mean absolute relative difference (MARD), overall, across arterial glucose strata, over different noradrenaline equivalent infusion rates, and over time since CGM start. MARD
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Pharmacology, Section of Anaesthesia and Intensive Care, Karolinska Institutet, Stockholm, Sweden.
- Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.
- Department of Medicine, NU-Hospital Group, Uddevalla, Sweden.
- Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.
- Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Clinical Science and Education, Section of Anaesthesia and Intensive Care, South General Hospital, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Ola Friman, Johan Mårtensson
Zitieren
APA
Friman, O., Soltani, N., Lind, M., Zetterqvist, P., Balintescu, A., Perner, A., Oldner, A., Rooyackers, O., & Mårtensson, J. (2024). Performance of Subcutaneous Continuous Glucose Monitoring in Adult Critically Ill Patients Receiving Vasopressor Therapy. Diabetes Technology & Therapeutics, 26(10), 763-772. https://doi.org/10.1089/dia.2024.0035
Vancouver
Friman O, Soltani N, Lind M, Zetterqvist P, Balintescu A, Perner A, et al. Performance of Subcutaneous Continuous Glucose Monitoring in Adult Critically Ill Patients Receiving Vasopressor Therapy. Diabetes Technology & Therapeutics. 2024;26(10):763-772. doi:10.1089/dia.2024.0035
BibTeX
@article{Friman2024,
author = {Friman, Ola and Soltani, Navid and Lind, Marcus and Zetterqvist, Pia and Balintescu, Anca and Perner, Anders and Oldner, Anders and Rooyackers, Olav and Mårtensson, Johan},
title = {Performance of Subcutaneous Continuous Glucose Monitoring in Adult Critically Ill Patients Receiving Vasopressor Therapy},
journal = {Diabetes Technology & Therapeutics},
year = {2024},
volume = {26},
number = {10},
pages = {763--772},
doi = {10.1089/dia.2024.0035}
}
EUVIMED